437 related articles for article (PubMed ID: 17053394)
41. Mediastinal uptake of I-131 in a hiatal hernia mimicking recurrence of papillary thyroid carcinoma.
Willis LL; Cowan RJ
Clin Nucl Med; 1993 Nov; 18(11):961-3. PubMed ID: 8269678
[TBL] [Abstract][Full Text] [Related]
42. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.
Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM
Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474
[TBL] [Abstract][Full Text] [Related]
43. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma.
David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC
Thyroid; 2005 Feb; 15(2):158-64. PubMed ID: 15753676
[TBL] [Abstract][Full Text] [Related]
44. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
Mazzaferri EL; Kloos RT
J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
46. I-131 uptake in the breast for thyroid cancer surveillance with biopsy-proven benign tissue.
Allen T; Wiest P; Vela S; Hartshorne M; Crooks LA
Clin Nucl Med; 1998 Sep; 23(9):585-7. PubMed ID: 9735978
[TBL] [Abstract][Full Text] [Related]
47. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
48. Nuclear imaging in the management of thyroid carcinoma.
Cavalieri RR
Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676
[TBL] [Abstract][Full Text] [Related]
49. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Ong SC; Ng DC; Sundram FX
Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
[TBL] [Abstract][Full Text] [Related]
50. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
Biscontini G; Possa M; Sara R; Milella M; Rossetti C
Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
[TBL] [Abstract][Full Text] [Related]
51. An Unusual False-Positive Uptake of Radioiodine in Pericardial Effusion on Posttherapy Scan.
Malhotra G; Moghe SH; Ranade R; Asopa RR
Clin Nucl Med; 2016 Jul; 41(7):568-9. PubMed ID: 27055143
[TBL] [Abstract][Full Text] [Related]
52. Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 milliCuries Radioiodine.
Mujammami M; Hier MP; Payne RJ; Rochon L; Tamilia M
Thyroid; 2016 Jul; 26(7):951-8. PubMed ID: 27150203
[TBL] [Abstract][Full Text] [Related]
53. Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine.
Kusacic Kuna S; Samardzic T; Tesic V; Medvedec M; Kuna K; Bracic I; Despot M; Dodig D
Nucl Med Commun; 2009 Apr; 30(4):263-9. PubMed ID: 19247212
[TBL] [Abstract][Full Text] [Related]
54. Low-iodine diet revisited: importance in nuclear medicine imaging and management.
Hinds SR; Stack AL; Stocker DJ
Clin Nucl Med; 2008 Apr; 33(4):247-50. PubMed ID: 18356660
[TBL] [Abstract][Full Text] [Related]
55. Littoral cell angioma presenting as metastatic thyroid carcinoma to the spleen.
Mohan V; Jones RC; Drake AJ; Daly PL; Shakir KM
Thyroid; 2005 Feb; 15(2):170-5. PubMed ID: 15753678
[TBL] [Abstract][Full Text] [Related]
56. Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation.
Vrachimis A; Schober O; Riemann B
Nuklearmedizin; 2012; 51(3):67-72. PubMed ID: 22294096
[TBL] [Abstract][Full Text] [Related]
57. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
Lee JI; Chung YJ; Park SJ; Ryu HS; Cho BY
Thyroid; 2012 Oct; 22(10):1084-7. PubMed ID: 22873179
[TBL] [Abstract][Full Text] [Related]
58. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
59. Long-term follow-up of a patient with papillary thyroid carcinoma, elevated thyroglobulin levels, and negative imaging studies.
Caplan RH; Wickus GG; Manske BR
Endocr Pract; 2005; 11(1):43-8. PubMed ID: 16033735
[TBL] [Abstract][Full Text] [Related]
60. [False positive scintigraphic images in the surveillance of differentiated thyroid cancers].
Rudoni S; Toubeau M; Mansuy S; Vaillant G; Verges B; Brun JM; Brunotte F
Ann Endocrinol (Paris); 1997; 58(5):399-407. PubMed ID: 9685998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
